WebinarHealthy Aging

Separating Geroprotection from Disease Modification to Repurpose Approved Drugs for Human Aging

Name: Separating Geroprotection from Disease Modification to Repurpose Approved Drugs for Human Aging
Start: 2026-10-27T20:00:00.000Z
End: 2026-10-27T21:00:00.000Z

MassAITC webinar flyer: Jesse Poganik, PhD, on separating geroprotection from disease modification to repurpose approved drugs for human aging, Tuesday, October 27, 4–5 pm EDT. — Event flyer

Speaker

Jesse Poganik, PhDInvestigator, Brigham and Women’s Hospital & Instructor in Medicine, Harvard Medical School

You’ll learn

How researchers developed a new method to distinguish between drugs’ direct geroprotective effects and their indirect effects from treating disease
Which commonly prescribed medications have genuine anti-aging properties, with implications for repurposing existing drugs to extend health span
The molecular mechanisms by which specific drugs alter biological aging trajectories and slow aging at the biochemical level